Literature DB >> 18577451

Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

Hajime Konno1, Tetsurou Handa, David E Alonzo, Lynne S Taylor.   

Abstract

Amorphous solid dispersions are used as a strategy to improve the bioavailability of poorly water-soluble compounds. When formulating with a polymer, it is important not only for the polymer to stabilize against crystallization in the solid state, but also to improve the dissolution profile through inhibiting crystallization from the supersaturated solution generated by dissolution of the amorphous material. In this study, the dissolution profiles of solid dispersions of felodipine formulated with poly(vinylpyrrolidone) (PVP), hydroxypropyl methylcellulose (HPMC) or hydroxypropyl methylcellulose acetate succinate (HPMCAS) were compared. In addition, concentration versus time profiles were evaluated for the supersaturated solutions of felodipine in the presence and absence of the polymers. HPMCAS was found to maintain the highest level of supersaturation for the greatest length of time for both the dissolution and solution crystallization experiments, whereas PVP was found to be the least effective crystallization inhibitor. All polymers appeared to reduce the crystal growth rates of felodipine at an equivalent supersaturation and this mechanism most likely contributes to the enhanced solution concentration values observed during dissolution of the amorphous solid dispersions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577451     DOI: 10.1016/j.ejpb.2008.05.023

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  45 in total

1.  Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Authors:  Feng Qian; Jennifer Wang; Ruiling Hartley; Jing Tao; Raja Haddadin; Neil Mathias; Munir Hussain
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

2.  Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.

Authors:  Kamil Wlodarski; Feng Zhang; Tongzhou Liu; Wieslaw Sawicki; Thomas Kipping
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

Review 3.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

4.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

5.  Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.

Authors:  Mohammad Reza Siahi-Shadbad; Saeed Ghanbarzadeh; Mohammad Barzegar-Jalali; Hadi Valizadeh; Alireza Taherpoor; Ghobad Mohammadi; Azim Barzegar-Jalali; Khosro Adibkia
Journal:  Adv Pharm Bull       Date:  2014-08-10

6.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

7.  Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Hitesh S Purohit; James D Ormes; Sugandha Saboo; Yongchao Su; Matthew S Lamm; Amanda K P Mann; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-04-28       Impact factor: 4.200

8.  Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.

Authors:  Deng-Guang Yu; Christopher Branford-White; Kenneth White; Xue-Lian Li; Li-Min Zhu
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

9.  Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.

Authors:  Taro Kojima; Kenjirou Higashi; Toyofumi Suzuki; Kazuo Tomono; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2012-01-05       Impact factor: 4.200

10.  Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.

Authors:  Anh Q Vo; Xin Feng; Jiaxiang Zhang; Feng Zhang; Michael A Repka
Journal:  Int J Pharm       Date:  2018-08-21       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.